Key Points
- SVP John Couling sold 7,273 shares at an average price of $68.75 for a total of $500,018.75, trimming his holding by 6.31% to 108,065 shares.
- Dolby beat estimates for the quarter with EPS of $0.99 vs. $0.70 expected and revenue of $307.02M; the company set FY2026 EPS guidance of $4.190–4.340 and the stock has an average analyst target of $92.
- Dolby raised its quarterly dividend to $0.36 (annualized $1.44) for a yield of 2.2%, up from the prior $0.33 and implying a dividend payout ratio of about 54.8%.
Dolby Laboratories (NYSE:DLB - Get Free Report) SVP John Couling sold 7,273 shares of the firm's stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $68.75, for a total value of $500,018.75. Following the completion of the transaction, the senior vice president owned 108,065 shares in the company, valued at approximately $7,429,468.75. This represents a 6.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Dolby Laboratories Price Performance
NYSE:DLB opened at $66.58 on Tuesday. The stock has a market capitalization of $6.36 billion, a PE ratio of 25.31 and a beta of 0.89. The business's 50-day simple moving average is $67.03 and its 200-day simple moving average is $71.33. Dolby Laboratories has a fifty-two week low of $64.02 and a fifty-two week high of $89.66.
Dolby Laboratories (NYSE:DLB - Get Free Report) last released its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.29. The business had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.Dolby Laboratories's revenue was up .7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, research analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.
Dolby Laboratories Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Tuesday, December 2nd. This is a boost from Dolby Laboratories's previous quarterly dividend of $0.33. Dolby Laboratories's dividend payout ratio (DPR) is currently 54.75%.
Institutional Investors Weigh In On Dolby Laboratories
Several hedge funds have recently added to or reduced their stakes in the company. First Horizon Corp purchased a new stake in shares of Dolby Laboratories in the 3rd quarter valued at $25,000. Hantz Financial Services Inc. raised its holdings in Dolby Laboratories by 166.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker's stock worth $25,000 after purchasing an additional 220 shares in the last quarter. MAI Capital Management boosted its position in Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock valued at $28,000 after acquiring an additional 162 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in Dolby Laboratories in the first quarter worth $29,000. Finally, Allworth Financial LP grew its holdings in Dolby Laboratories by 590.4% in the second quarter. Allworth Financial LP now owns 504 shares of the electronics maker's stock worth $37,000 after purchasing an additional 431 shares during the period. Institutional investors own 58.56% of the company's stock.
Analysts Set New Price Targets
DLB has been the topic of several recent analyst reports. Weiss Ratings reiterated a "hold (c-)" rating on shares of Dolby Laboratories in a research note on Monday, December 8th. Baird R W upgraded shares of Dolby Laboratories to a "hold" rating in a research report on Friday, September 5th. Robert W. Baird initiated coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a "neutral" rating and a $74.00 price objective for the company. Wall Street Zen lowered Dolby Laboratories from a "buy" rating to a "hold" rating in a report on Saturday, November 22nd. Finally, Rosenblatt Securities decreased their target price on shares of Dolby Laboratories from $95.00 to $85.00 and set a "buy" rating for the company in a research report on Wednesday, November 19th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $92.00.
Read Our Latest Report on DLB
Dolby Laboratories Company Profile
(
Get Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
